Tempong, Andresto A.

HRN: 28-45-51  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2026
04/13/2026
IV
500mg
Q8
Infectious Diarrhea
Checking Initial Appropriateness 
04/06/2026
CIPROFLOXACIN 500MG (TAB)
04/06/2026
04/12/2026
ORAL
500mg
BID
Amoebiasis
Checking Initial Appropriateness 
04/08/2026
METRONIDAZOLE 500MG (TAB)
04/08/2026
04/14/2026
PO
500mgtab
TID
Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: